WHO ICTRP trial

A multicentre, randomised, double-blind, placebo-controlled parallel group…

EUCTR2004-004924-11-DE · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2004-004924-11-DE
Public title A multicentre, randomised, double-blind, placebo-controlled parallel group clinical trial to investigate the efficacy and safety of specific sublingual immunotherapy with SLIT One birch in patients with seasonal birch pollen induced rhinoconjunctivitis - SLIT One Birch Study
Scientific title A multicentre, randomised, double-blind, placebo-controlled parallel group clinical trial to investigate the efficacy and safety of specific sublingual immunotherapy with SLIT One birch in patients with seasonal birch pollen induced rhinoconjunctivitis - SLIT One Birch Study
Primary sponsor ALK-Abelló A/S
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries Germany
Conditions Desensibilisierung gegenüber Allergenen
Interventions Product Name: SLIT One birch Pharmaceutical Form: Oral solution INN or Proposed INN: Betula verrucosa (Bet v 1) Concentration type: equal Concentration number: 1000-STU/ml Pharmaceutical form of the placebo: Oral solution Route of…
Registration date Feb 25, 2005
Secondary IDs SHX0712
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations